Tag: FDA

Biocon Says U.S. FDA Proposal Could Cut Biosimilar Cost...

Biocon expects U.S. FDA’s plan to reduce clinical trial demands for biosimilars ...

This information is not an offer to buy, sell, or hold any cryptocurrency. Individuals who may copy within the CopyTrader Program are not deemed investment advisors and their performances in the past are not indicative of future results. All investment and copy trading carries risk and you should do your due diligence before investing.